The practical benefits of pharmacokinetics in the use of antineoplastic agents
- 1 August 1980
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 4 (3) , 139-145
- https://doi.org/10.1007/bf00254011
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- When Should Plasma Drug Levels be Monitored?Drugs, 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant diseasePublished by Elsevier ,1978
- Comparison of two radioimmunoassays and a microbiologic assay for bleomycinMedical and Pediatric Oncology, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977
- Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.Journal of Clinical Investigation, 1975
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternPublished by Elsevier ,1972
- The role of phosphopyridinenucleotides in the metabolism of cortisol by peripheral tissueBiochimica et Biophysica Acta, 1960